Feb 15 |
Renalytix AI GAAP EPS of -$0.09, revenue of $0.7M
|
Feb 15 |
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
|
Feb 13 |
Why ZoomInfo Technologies Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
|
Feb 12 |
Renalytix surges after Medicare draft decision on lead product
|
Feb 9 |
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
|
Jan 10 |
New published data demonstrates KidneyIntelXâ„¢ has broad implications for winning war on chronic kidney disease
|
Nov 14 |
Renalytix Plc (RNLX) Q1 2024 Earnings Call Transcript
|
Nov 14 |
Renalytix AI GAAP EPS of -$0.11 misses by $0.01, revenue of $0.46M misses by $0.25M
|
Nov 14 |
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
|